PT76296B - Novel glycoproteins processes for their production and therapeutic agents for tumors which contain such glycoproteins - Google Patents

Novel glycoproteins processes for their production and therapeutic agents for tumors which contain such glycoproteins

Info

Publication number
PT76296B
PT76296B PT76296A PT7629683A PT76296B PT 76296 B PT76296 B PT 76296B PT 76296 A PT76296 A PT 76296A PT 7629683 A PT7629683 A PT 7629683A PT 76296 B PT76296 B PT 76296B
Authority
PT
Portugal
Prior art keywords
glycoproteins
tumors
contain
processes
production
Prior art date
Application number
PT76296A
Other languages
English (en)
Other versions
PT76296A (en
Original Assignee
Mochida Pharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP57028992A external-priority patent/JPS58148826A/ja
Priority claimed from JP57028993A external-priority patent/JPS58146293A/ja
Priority claimed from JP57087674A external-priority patent/JPS58203917A/ja
Priority claimed from JP57087675A external-priority patent/JPS58203918A/ja
Priority claimed from JP57108046A external-priority patent/JPS58225024A/ja
Application filed by Mochida Pharm Co Ltd filed Critical Mochida Pharm Co Ltd
Publication of PT76296A publication Critical patent/PT76296A/pt
Publication of PT76296B publication Critical patent/PT76296B/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806Antigenic peptides or proteins
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • Y10S530/809Fused cells, e.g. hybridoma
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827Proteins from mammals or birds
    • Y10S530/828Cancer
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827Proteins from mammals or birds
    • Y10S530/829Blood

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PT76296A 1982-02-26 1983-02-25 Novel glycoproteins processes for their production and therapeutic agents for tumors which contain such glycoproteins PT76296B (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP57028992A JPS58148826A (ja) 1982-02-26 1982-02-26 糖蛋白質および腫瘍治療剤
JP57028993A JPS58146293A (ja) 1982-02-26 1982-02-26 抗腫瘍性糖蛋白質の製造方法
JP57087674A JPS58203917A (ja) 1982-05-24 1982-05-24 糖蛋白質およびその製法ならびに腫瘍治療剤
JP57087675A JPS58203918A (ja) 1982-05-24 1982-05-24 糖蛋白質およびその製造法ならびに腫瘍治療剤
JP57108046A JPS58225024A (ja) 1982-06-23 1982-06-23 糖蛋白質およびその製造方法ならびに腫瘍治療剤

Publications (2)

Publication Number Publication Date
PT76296A PT76296A (en) 1983-03-01
PT76296B true PT76296B (en) 1985-11-12

Family

ID=27521092

Family Applications (1)

Application Number Title Priority Date Filing Date
PT76296A PT76296B (en) 1982-02-26 1983-02-25 Novel glycoproteins processes for their production and therapeutic agents for tumors which contain such glycoproteins

Country Status (17)

Country Link
US (1) US4481137A (pt)
BE (1) BE896027A (pt)
BR (1) BR8300933A (pt)
DD (1) DD209634A5 (pt)
DE (1) DE3306297A1 (pt)
DK (1) DK93383A (pt)
FI (1) FI830638L (pt)
FR (1) FR2522267A1 (pt)
GB (1) GB2117385B (pt)
GR (1) GR78097B (pt)
LU (1) LU84662A1 (pt)
NL (1) NL8300727A (pt)
NO (1) NO830669L (pt)
PL (1) PL240784A1 (pt)
PT (1) PT76296B (pt)
RO (1) RO85901B (pt)
SE (1) SE8301073L (pt)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4920196A (en) * 1982-07-30 1990-04-24 Genentech, Inc. Human lymphotoxin
DE3334405A1 (de) * 1983-09-23 1985-04-04 Behringwerke Ag, 3550 Marburg Membranassoziierte proteine (mp(pfeil abwaerts)2(pfeil abwaerts)), verfahren zu ihrer gewinnung sowie ihre verwendung
JPS60112718A (ja) * 1983-11-21 1985-06-19 Kyorin Pharmaceut Co Ltd 抗腫瘍作用を示す蛋白性物質及びその製造方法
US4758549A (en) * 1983-12-13 1988-07-19 Kabushiki Kaisha Mayashibara Seibutsu Kagaku Kenkyujo Lymphokine, monoclonal antibody specific to the lymphokine and their production and uses
US4879226A (en) * 1984-04-06 1989-11-07 Asahi Kasei Kogyo Kabushiki Kaisha Novel human physiologically active polypeptide
US4959457A (en) * 1984-05-31 1990-09-25 Genentech, Inc. Anti-lymphotoxin
US5683688A (en) * 1984-05-31 1997-11-04 Genentech, Inc. Unglycosylated recombinant human lymphotoxin polypeptides and compositions
US5672347A (en) * 1984-07-05 1997-09-30 Genentech, Inc. Tumor necrosis factor antagonists and their use
US6686455B1 (en) 1984-07-05 2004-02-03 Genentech, Inc. Tumor necrosis factor
FR2568125B1 (fr) * 1984-07-25 1988-04-15 Kogo Michiko Agent anti-tumeur contenant la proteine du sucre
US5019385A (en) * 1984-11-09 1991-05-28 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Novel lymphopine LK 2 and pharmaceutic compositions containing same
JPH0631318B2 (ja) * 1985-09-18 1994-04-27 株式会社林原生物化学研究所 新リンホカインiiiとその製法
US4822605A (en) * 1986-02-18 1989-04-18 Exovir, Inc. Compositions and methods employing the same for the treatment of viral and cancerous skin lesions and the like
WO1990000400A1 (en) * 1988-07-15 1990-01-25 The Trustees Of Columbia University In The City Of New York Tumor necrosis enhancing factor and methods of preparation and use
US5106745A (en) * 1989-12-06 1992-04-21 Board Of Regents, The University Of Texas System Broad spectrum virus inhibitor, UTI-β
JP3552240B2 (ja) * 1993-02-23 2004-08-11 第一製薬株式会社 高濃度tcf製剤
US5641867A (en) * 1993-09-29 1997-06-24 The Trustees Of Columbia University In The City Of New York Antibody which specifically binds to endothelial-monocyte activating polypeptide II
JP4006058B2 (ja) * 1997-03-11 2007-11-14 第一三共株式会社 多臓器不全予防及び/又は治療剤
WO1998041230A1 (fr) * 1997-03-14 1998-09-24 Snow Brand Milk Products Co., Ltd. Agent preventif et/ou curatif de la cachexie
BG65084B1 (bg) * 2002-03-13 2007-02-28 Закрьiтое Акционерное Общество, Производственное Предприятие"Эндо-Фарм-А" Нов клас биоактивни гликопротеини
US7341841B2 (en) * 2003-07-12 2008-03-11 Accelr8 Technology Corporation Rapid microbial detection and antimicrobial susceptibility testing
JP4773348B2 (ja) * 2003-07-12 2011-09-14 アクセラー8 テクノロジー コーポレイション 高感度かつ迅速なバイオ検出法
US20120077206A1 (en) 2003-07-12 2012-03-29 Accelr8 Technology Corporation Rapid Microbial Detection and Antimicrobial Susceptibility Testing
US10254204B2 (en) 2011-03-07 2019-04-09 Accelerate Diagnostics, Inc. Membrane-assisted purification
ES2551922T3 (es) 2011-03-07 2015-11-24 Accelerate Diagnostics, Inc. Sistemas rápidos de purificación celular
US9677109B2 (en) 2013-03-15 2017-06-13 Accelerate Diagnostics, Inc. Rapid determination of microbial growth and antimicrobial susceptibility
US10253355B2 (en) 2015-03-30 2019-04-09 Accelerate Diagnostics, Inc. Instrument and system for rapid microorganism identification and antimicrobial agent susceptibility testing
AU2016243656A1 (en) 2015-03-30 2017-11-09 Accelerate Diagnostics, Inc. Instrument and system for rapid microorganism identification and antimicrobial agent susceptibility testing

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2726886A1 (de) * 1977-06-15 1979-01-18 Behringwerke Ag Neues glykoprotein und verfahren zu dessen herstellung
JPS6030291B2 (ja) * 1978-03-20 1985-07-16 森永乳業株式会社 人顆粒球の分化増殖を促進するhgi糖蛋白質、hgi糖蛋白質の製造法及びhgi糖蛋白質を含有する白血球減少症治療剤
US4261976A (en) * 1978-10-03 1981-04-14 The Massachusetts General Hospital Method and glycoprotein composition for inhibition of growth of transformed cells and tumors
US4243582A (en) * 1979-04-26 1981-01-06 Monsanto Company Novel glycoproteins from bovine cartilage

Also Published As

Publication number Publication date
US4481137A (en) 1984-11-06
DK93383A (da) 1983-08-27
DD209634A5 (de) 1984-05-16
GB2117385B (en) 1985-05-09
NO830669L (no) 1983-08-29
BR8300933A (pt) 1983-11-16
GB8305330D0 (en) 1983-03-30
PL240784A1 (en) 1983-11-07
GB2117385A (en) 1983-10-12
RO85901B (ro) 1985-01-30
SE8301073D0 (sv) 1983-02-25
NL8300727A (nl) 1983-09-16
SE8301073L (sv) 1983-08-27
DK93383D0 (da) 1983-02-25
DE3306297A1 (de) 1983-09-15
LU84662A1 (fr) 1983-09-08
GR78097B (pt) 1984-09-26
BE896027A (fr) 1983-08-25
FI830638A0 (fi) 1983-02-25
PT76296A (en) 1983-03-01
FR2522267A1 (fr) 1983-09-02
RO85901A (ro) 1985-01-24
FI830638L (fi) 1983-08-27

Similar Documents

Publication Publication Date Title
PT76296A (en) Novel glycoproteins processes for their production and therapeutic agents for tumors which contain such glycoproteins
GB2116036B (en) Treatment of acne
GB2125986B (en) Device for the treatment of cancers
CY1470A (en) Process for the preparation of phenylalkylaminoethylsalicylamide
ZA843764B (en) Ore irradiator divider
EG16991A (en) Therapeutic agents
GB8317357D0 (en) Therapeutic composition
DE3360101D1 (en) Process for the manufacture of reactive-dye preparations
GB8310991D0 (en) Ore irradiator
GB8510892D0 (en) Products for treating cancer
ZA831109B (en) Glycoproteins,processes for their production and therapeutic agents for tumors which contain such glycoproteins
GB2150800B (en) Ore irradiator
DE3362429D1 (en) Process for the preparation of thiadiazoloxyacetamides
DE3361356D1 (en) Process for the preparation of 3-acylaminoanilines
DE3360384D1 (en) Process for the preparation of 1-hydroxyketones
GB8319703D0 (en) Diathermy apparatus
DE3269747D1 (en) Process for the preparation of carbamates
GB2118173B (en) Process for the manufacture of nitrophenetoles
DE3365382D1 (en) Process for the preparation of 2-chlorobenzoxazols
ZA836848B (en) Therapeutic agents
PT77495B (en) Process for the manufacture of dibenzazepine-carboxamides
DE3267818D1 (en) Earfittings for earrings
GB8329948D0 (en) Biomagnetic healing apparatus
DE3371040D1 (en) Air injection bath for balneo therapy or thalasso therapy
DE3365483D1 (en) Process for the preparation of 2-alkylthiomethyl-4-hydroxy-pyrimidines